Site Search

Share

X

Search Results

Montgomery County Smoking Ban Has Positive Impact on Businesses

... Councilmember Phil Andrews’ announcement that sales tax receipts in the county increased 7.2 percent or nearly $2 million since enactment of its smoking ban last fall. Councilmember Andrews’ data compares tax receipts from October 2003 through March 2004 to those from the same ... adults including at least 690 nonsmokers. Tobacco use costs the U.S. economy $82 billion a year in lost productivity. Smoking related illnesses cost the state of Maryland $1.53 billion annually. Smoke-free policies decrease absenteeism among non-smoking employees, reduce housekeeping and maintenance costs, lower insurance rates and result in fewer smoking-related fires. The American Cancer Society Cancer Action Network (ACS CAN) is the nonprofit, nonpartisan sister issue advocacy organization of the American Cancer Society. ACS CAN is dedicated to eliminating cancer as ...

Cancer Advocates Send ‘SOS’ to OK Capitol: Save Our Screenings to Save Lives

OKLAHOMA CITY – Cancer survivors, health professionals and students will convene at the Capitol on Monday, April 16, seeking restoration of the state’s Colorectal Cancer Screening Fund and protection for current life-saving programs. Colorectal cancer is the second deadliest type ... help balance the 2018 budget. The Legislature swept any remaining dollars from the Colorectal Cancer Screening Fund, permanently closing it. Low-cost to no-cost cancer screenings save lives – especially for those who avoid the hospital because of dollar signs at a detriment of their health. Colorectal cancer is a disease that can be treated successfully if found early enough or even prevented altogether with the removal of polyps during a colonoscopy. ACS CAN volunteers ...

Victory for cancer patients: US House passes health care reform

If you were flipping the channels on Saturday night and accidentally passed by C-Span, you missed an important vote in the U.S. House of Representatives.ξ At 10:57 p.m. EST, the House passed health care reform with 220 votes, including one Republican. This vote was a victory for cancer patients.ξ Thanks to the great support of our volunteers over the past two years, ACS CAN was able to get many key provisions included in the bill.ξ They included: Refocusing the system to emphasize prevention Ending the practice of denying coverage because of pre-existing conditions Limiting the cost burden on families by providing care that covers more and costs less Emphasizing patientsŠ—È quality of life "If enacted, this bill could ...

Proposed Legislation Gives Cancer Patients Improved Access to Treatments

Missouri Coalition for Cancer Treatment Access, Wednesday, January 15, 2014: On behalf of thousands of Missouri cancer patients, survivors and their families, the Missouri Coalition for Cancer Treatment Access, applauds the proposed ... of life for our patients and their caregivers, including the convenience of not having to travel several times a week for IV infusions that can take several hours each time,” said Debbie Kersting, Executive Director, The Leukemia & Lymphoma Society – Gateway Chapter. This ... because oral cancer drugs in Missouri are covered as a pharmacy benefit, patients can be charged high co-insurances, up to 50 percent of the cost of the therapy, even if the oral drugs are the only treatment available. This can result in out-of-pocket costs of hundreds to thousands of ...

Association Health Plan Rule Likely to Divide Insurance Market; Strip Patient Protections

Today the Department of Labor issued final rules governing the creation of association health plans (AHP). Under the rule, AHPs would be exempt from current benefit and cost-sharing requirements. Such plans could, for example, exclude coverage for prescription drugs or other essential health benefits, cap coverage ... could have the same effect as considering someone’s health history.  A statement from the American Cancer Society Cancer Action Network (ACS CAN) follows: “This rule will seriously erode the availability of affordable comprehensive coverage in most states’ individual and small group ...

Protect Funding for Tobacco Prevention and Cessation Programs

Tobacco use remains Texas’ leading preventable cause of death and is the leading cause of cancer deaths in Texas. An estimated 28,000 Texans die annually from tobacco-related illnesses.   Texas spends nearly $9 billion in annual ... care costs. And importantly: It will prevent children from becoming addicted adult smokers.   During the 2017 Texas Legislative session, ACS CAN was unsuccessful in turning back drastic cuts to tobacco prevention funding at the Department of State Health Services that unfortunately ended ...

Health Advocates Urge Wyoming Legislature to Pass $1 Tobacco Tax Increase 

  CHEYENNE, Wyo.—Feb. 13, 2018—Cancer advocates and volunteers from the American Cancer Society Cancer Action Network (ACS CAN) and the American Heart Association gathered in Cheyenne on Tuesday, February 13 for a Day at the Capitol to urge their state lawmakers to ... lawmakers to support the Revenue Committee’s House Bill 43, which would raise Wyoming’s cigarette tax by $1 per pack and increase the price of all other tobacco products like chewing tobacco at equal amounts. The Revenue Committee will introduce HB 43 this week. Each year, 800 Wyoming ... smoking. At current rates, 12,000 Wyoming kids alive today will die prematurely from a tobacco-related illness. "Tobacco use is the top cause of preventable death in our state, and smoking causes nearly 30 percent of all cancer deaths in Wyoming," said Jason Mincer, ACS CAN Wyoming ...

Frequently Asked Questions About Biologic and Biosimilar Drugs

Q. What is a biologic?  Answer: Biologics are a class of drugs that are produced using a living system, such as a microorganism, plant cell, or animal cell. Like all drugs, biologics are regulated by ... as the reference product. A biosimilar must have no clinical differences to the reference product. This means that a patient using a biosimilar can expect the same physical responses to the biosimilar as they would to the reference product. A biosimilar is considered highly similar to the ... of biosimilars. In 2010, FDA was given the authority to approve versions of biologic products that would provide competition and likely lower cost alternatives to “brand name” biologics.  The biosimilar pathway depends on a head-to-head comparison of the proposed biosimilar to a ...

Congress Introduces PSA Screening for HIM Act

... for HIM Act, which would require insurance companies to cover prostate cancer screenings for those at high risk for the disease without out-of-pocket costs. By removing cost barriers for individuals, more people at high risk can receive the necessary screenings to detect prostate cancer in its earliest stages, often before any symptoms of the disease are present. ...

Bipartisan Legislation Would Make It Easier for All Patients to Participate in Clinical Trials

... changes to policy are beneficial to both patients and researchers because they would expand socioeconomic, geographic, and racial diversity of trial participants. A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows: “ACS CAN is committed to not only increasing patient participation in clinical trials but also ensuring diversification of trial ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy